DAFORMFILLABLE.COM | DA FORM 5441-46 Fillable – Army Pubs 5441-46 PDF – DA FORM 5441-46, titled “Evaluation of Clinical Privileges – Pulmonary Disease,” is an essential document in the realm of military healthcare. This form is used to assess and document the clinical privileges of healthcare professionals specializing in pulmonary disease within the military medical system. Here, we will explore the key aspects of this form, its significance, and the procedures associated with it.
DA FORM 5441-46 – Evaluation Of Clinical Privileges – Pulmonary Disease
Form Number | DA Form 5441-46 |
Form Title | Evaluation Of Clinical Privileges – Pulmonary Disease |
Form Date | 02/01/2004 |
Form Proponent | TSG |
What is DA FORM 5441-46?
DA FORM 5441-46 is a standardized form used by the U.S. Army to evaluate the clinical privileges of medical personnel in the field of pulmonary disease. This form ensures that healthcare providers are qualified to perform specific medical procedures and deliver care to patients with pulmonary conditions.
Key Details of DA FORM 5441-46:
- Pub/Form Number: DA FORM 5441-46
- Pub/Form Date: 02/01/2004
- Pub/Form Title: Evaluation of Clinical Privileges – Pulmonary Disease
- Pub/Form Proponent: TSG (The Surgeon General)
- Pub/Form Status: ACTIVE
- Prescribed Forms/Prescribing Directive: AR 40-68
- Footnotes:
- 14: Requires Privacy Act Statement (AR 340-21)
- 42: Item Only Produced in Electronic Media
- Security Classification: UNCLASSIFIED
- Distribution Restriction Code: A Approved for public release; distribution is unlimited
- Pub/Form IDN: 990001
- Pub/Form PIN: 081287
Purpose and Importance of DA FORM 5441-46
The primary purpose of DA FORM 5441-46 is to ensure that healthcare providers specializing in pulmonary disease are adequately trained and competent in their field. This form plays a critical role in maintaining high standards of care within the military healthcare system by evaluating the qualifications and performance of medical personnel.
Key Aspects Evaluated:
- Clinical Skills and Competence: Assessment of the provider’s ability to perform specific procedures and manage pulmonary diseases effectively.
- Professional Experience: Review of the provider’s clinical experience, including training and previous evaluations.
- Continuing Education: Verification of ongoing education and training to stay updated with the latest medical practices and advancements in pulmonary disease.
Procedures for Completing DA FORM 5441-46
Completing DA FORM 5441-46 involves a thorough review process, typically conducted by senior medical personnel or a credentials committee. Here are the steps involved:
Step 1: Collection of Information
The healthcare provider must provide detailed information about their clinical training, experience, and previous evaluations related to pulmonary disease.
Step 2: Evaluation of Clinical Competence
Senior medical personnel or the credentials committee evaluates the provider’s clinical skills and competence. This evaluation includes observing procedures, reviewing case logs, and assessing outcomes.
Step 3: Documentation and Approval
Once the evaluation is complete, the results are documented on DA FORM 5441-46. The form is then reviewed and approved by the appropriate authority, ensuring that the provider meets the required standards.
Privacy and Security Considerations
According to the footnotes on DA FORM 5441-46, it requires a Privacy Act Statement (AR 340-21), which ensures that all personal information collected during the evaluation process is handled with confidentiality and security. The form is also produced only in electronic media to streamline the process and maintain accuracy.
Conclusion
DA FORM 5441-46 – Evaluation of Clinical Privileges – Pulmonary Disease is a crucial document for ensuring the quality and competence of healthcare providers in the military. By following the prescribed procedures and maintaining strict privacy standards, this form helps uphold the integrity and efficiency of the military medical system, ultimately contributing to better patient care and outcomes.
For more detailed information or to access the form, please refer to the prescribing directive AR 40-68 and ensure compliance with all relevant guidelines and procedures.